ORAPIORAPIORAPI

ORAPI

No trades
See on Supercharts
Market capitalization
‪43.15 M‬EUR
−2.86EUR
‪−18.82 M‬EUR
‪229.10 M‬EUR
‪2.20 M‬
Beta (1Y)
0.58

About ORAPI

CEO
Guy Chifflot
Headquarters
Saint-Vulbas
Website
Founded
1976
ISIN
FR0000075392
FIGI
BBG000C47QM8
Orapi SA engages in the design, manufacture, and distribution of hygiene products and industrial processes. It operates through the following geographical segments: Northern Europe, Southern Europe, North America, and Asia and Rest of the world. Its products are known under the brand names Garcin Bactynil, Orapi Hygiene, Spado, Fury, Gloss, and Wyritol. The company was founded by Guy Chifflot on August 14, 1968 and is headquartered in Saint-Vulbas, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ORAP is 6.52 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange ORAPI stocks are traded under the ticker ORAP.
ORAP stock is 0% volatile and has beta coefficient of 0.58. Check out the list of the most volatile stocks — is ORAPI there?
One year price forecast for ORAPI has a max estimate of 6.00 EUR and a min estimate of 6.00 EUR.
Yes, you can track ORAPI financials in yearly and quarterly reports right on TradingView.
ORAP stock has risen by 0.31% compared to the previous week, the month change is a 0.31% rise, over the last year ORAPI has showed a 60.20% increase.
ORAP net income for the last quarter is ‪−13.00 M‬ EUR, while the quarter before that showed ‪−5.82 M‬ EUR of net income which accounts for −123.41% change. Track more ORAPI financial stats to get the full picture.
No, ORAP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ORAP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORAPI stock right from TradingView charts — choose your broker and connect to your account.
ORAP reached its all-time high on Apr 7, 2014 with the price of 19.54 EUR, and its all-time low was 3.22 EUR and was reached on Dec 27, 2019.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORAPI technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORAPI stock shows the buy signal. See more of ORAPI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ORAPI future price: according to them, ORAP price has a max estimate of 6.00 EUR and a min estimate of 6.00 EUR. Read a more detailed ORAPI forecast: see what analysts think of ORAPI and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORAPI EBITDA is ‪15.86 M‬ EUR, and current EBITDA margin is 6.92%. See more stats in ORAPI financial statements.